Actualités Fisher Scientific - FSH | Actions New York Stock Exchange

Fisher Scientific Reports Record Quarterly Financial Results; Company Announces Second-Quarter Adjusted EPS of $1.10

Fisher Scientific International Inc. (NYSE: FSH), the world leader in serving science, today reported record sales and earnings for the second...

Fisher Scientific to Issue Earnings Release

Fisher Scientific International Inc. (NYSE: FSH) will issue a press release regarding its second-quarter and year-to-date results on Tuesday, July...

Harvard and Stanford Medical Schools and VUmc Join 12 International Research Centers and Dharmacon as Members of RNAi Global In

The Genome-Wide RNAi Global Initiative (RNAi Global), an alliance of Dharmacon, Inc. and leading international research centers pioneering the use...

Abbott and Dharmacon Collaborate to Develop New siRNA-Based Therapeutics

- Partnership Addresses Disease Targets Previously Untapped by Traditional Drug Discovery Efforts - ABBOTT PARK, Ill. and LAFAYETTE, Colo., July...

Fisher Biosciences Licenses Expanded PCR Rights from Applied Biosystems

Fisher Biosciences announced today that, through Fisher Scientific, it has entered into an expanded PCR (polymerase chain reaction) licensing...

Dharmacon and amaxa Collaborate to Improve siRNA Delivery into Cells; Nucleofector(R) Technology Enables siRNA Transfer into Pr

Dharmacon, Inc., a business unit of the Fisher Biosciences group and the world's leading supplier of innovative RNA and RNA interference (RNAi...

NIH Names Fisher Biosciences Unit, Pierce, Preferred Vendor for Multiplex Protein Profiling

The National Institutes of Health (NIH) is partnering with Pierce Biotechnology, a unit of Fisher Biosciences, as a preferred vendor to conduct...

RNAi Global Initiative Members Advance Standards for Genome-Wide RNAi Research in Second Meeting; Dharmacon and 14 Leading Rese

The Genome-Wide RNAi Global Initiative (RNAi Global), an alliance of Dharmacon, Inc. and 14 leading international research centers pioneering the...

Fox Chase Cancer Center Joins Dharmacon and International Research Institutes as Newest Member of the Genome-Wide RNAi Global I

The Genome-Wide RNAi Global Initiative, an alliance of Dharmacon, Inc. and leading international research centers pioneering the use of whole...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Fisher Scientific (FSH)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

FSH Actualités

Fisher Scientific Reports Record Quarterly Financial Results; Company Announces Second-Quarter Adjusted EPS of $1.10

Fisher Scientific to Issue Earnings Release

Harvard and Stanford Medical Schools and VUmc Join 12 International Research Centers and Dharmacon as Members of RNAi Global In

Abbott and Dharmacon Collaborate to Develop New siRNA-Based Therapeutics

Fisher Biosciences Licenses Expanded PCR Rights from Applied Biosystems

Dharmacon and amaxa Collaborate to Improve siRNA Delivery into Cells; Nucleofector(R) Technology Enables siRNA Transfer into Pr

NIH Names Fisher Biosciences Unit, Pierce, Preferred Vendor for Multiplex Protein Profiling

RNAi Global Initiative Members Advance Standards for Genome-Wide RNAi Research in Second Meeting; Dharmacon and 14 Leading Rese

Strong Influence of Brand Differentiation on Life Science Market Competition

Seven Summits Research Releases Alerts on ADM, CMX, FSH, HLT, and NTMD

Fisher Scientific Reports First-Quarter Pro Forma EPS of 90 Cents; Company Reiterates 2006 EPS Range of $4.05 - $4.20

Fisher Scientific to Host Earnings Call

Fisher Scientific Expands its Biopharma Services Offering; Company to Acquire Clintrak Pharmaceutical Services

2006 Life Science Industry Awards Winners

Fox Chase Cancer Center Joins Dharmacon and International Research Institutes as Newest Member of the Genome-Wide RNAi Global I

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Fisher Scientific (FSH) Actualités

Fisher Scientific (FSH)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

FSH Actualités

Fisher Scientific Reports Record Quarterly Financial Results; Company Announces Second-Quarter Adjusted EPS of $1.10

Fisher Scientific to Issue Earnings Release

Harvard and Stanford Medical Schools and VUmc Join 12 International Research Centers and Dharmacon as Members of RNAi Global In

Abbott and Dharmacon Collaborate to Develop New siRNA-Based Therapeutics

Fisher Biosciences Licenses Expanded PCR Rights from Applied Biosystems

Dharmacon and amaxa Collaborate to Improve siRNA Delivery into Cells; Nucleofector(R) Technology Enables siRNA Transfer into Pr

NIH Names Fisher Biosciences Unit, Pierce, Preferred Vendor for Multiplex Protein Profiling

RNAi Global Initiative Members Advance Standards for Genome-Wide RNAi Research in Second Meeting; Dharmacon and 14 Leading Rese

Strong Influence of Brand Differentiation on Life Science Market Competition

Seven Summits Research Releases Alerts on ADM, CMX, FSH, HLT, and NTMD

Fisher Scientific Reports First-Quarter Pro Forma EPS of 90 Cents; Company Reiterates 2006 EPS Range of $4.05 - $4.20

Fisher Scientific to Host Earnings Call

Fisher Scientific Expands its Biopharma Services Offering; Company to Acquire Clintrak Pharmaceutical Services

2006 Life Science Industry Awards Winners

Fox Chase Cancer Center Joins Dharmacon and International Research Institutes as Newest Member of the Genome-Wide RNAi Global I

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités